Acenxion Biosytems
Acenxion Biosytems is a startup headquartered in Lawrence, United States, founded in 2020. It has raised at least $1.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Acenxion Biosytems has raised at least $1.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Acenxion Biosytems sits inside the Lawrence region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Lawrence
Related
Questions and answers
What does Acenxion Biosytems do?
Acenxion Biosytems is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Acenxion Biosytems raised?
At least $1.1m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Acenxion Biosytems based?
Acenxion Biosytems is headquartered in Lawrence, United States.
When was Acenxion Biosytems founded?
Acenxion Biosytems was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.